Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Colorado University Cancer Center member Dan Pollyea, MD, says the disease can still be deadly despite advances in treatment.
Hospitals are filling up with COVID-19 patients and other medical conditions are going untreated.
Hematologist John Byrd, MD, is chair of the Department of Internal Medicine at the University of Cincinnati College of Medicine.
COVID-19 vaccines are safe for people with cancer.
Certain types of cancer treatment can lead to inadequate immune response.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
A study from the Leukemia & Lymphoma Society finds that antibody production varies widely across blood cancer types.
These findings, however, may reflect regional attitudes in Utah and the surrounding area.
Sonia Dolinger runs a meal delivery business and fundraises for cancer research. She has chronic lymphocytic leukemia.
The monoclonal antibody reduces the risk of disease progression or death by 45%.
More than 70% of people treated with Abecma, a customized immunotherapy, experienced complete or partial remission.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.